XML 49 R32.htm IDEA: XBRL DOCUMENT v3.8.0.1
Accounting Policies - Impact of New Revenue Recognition Standard on Financial Statement Line Items (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Jan. 02, 2018
Dec. 31, 2017
Condensed Consolidated Statements of Income        
Net revenue $ 45,693      
Cost of revenue 38,834 $ 37,943    
Gross profit 6,859 6,571    
Operating profit 1,946 1,793    
Income before income tax provision 1,470 1,534    
Income tax provision 472 572    
Income from continuing operations 998 962    
Net income 998 953    
Net income attributable to CVS Health 998 952    
Condensed Consolidated Balance Sheets        
Accrued expenses 7,724   $ 6,626 $ 6,609
Deferred income taxes 3,058   2,992 2,996
Total Liabilities 96,462   57,449 57,436
Retained earnings 44,040   43,543 43,556
Total CVS Health shareholders’ equity 38,673   37,678 37,691
Total shareholders’ equity 38,677   37,682 37,695
Total liabilities and shareholders’ equity 135,139     95,131
Reconciliation of net income to net cash provided by operating activities:        
Net income 998 953    
Deferred income taxes and other noncash items 62 14    
Accrued expenses 1,231 $ 1,848    
ASU 2014-09 | Adjustment        
Condensed Consolidated Statements of Income        
Net revenue 7      
Cost of revenue 4      
Gross profit 3      
Operating profit 3      
Income before income tax provision 3      
Income tax provision 1      
Income from continuing operations 2      
Net income 2      
Net income attributable to CVS Health 2      
Condensed Consolidated Balance Sheets        
Accrued expenses (20)   17  
Deferred income taxes 5   (4)  
Total Liabilities (15)   13  
Retained earnings 15   (13)  
Total CVS Health shareholders’ equity 15   (13)  
Total shareholders’ equity 15   $ (13)  
Reconciliation of net income to net cash provided by operating activities:        
Net income 2      
Deferred income taxes and other noncash items 1      
Accrued expenses (3)      
ASU 2014-09 | As previously reported        
Condensed Consolidated Statements of Income        
Net revenue 45,700      
Cost of revenue 38,838      
Gross profit 6,862      
Operating profit 1,949      
Income before income tax provision 1,473      
Income tax provision 473      
Income from continuing operations 1,000      
Net income 1,000      
Net income attributable to CVS Health 1,000      
Condensed Consolidated Balance Sheets        
Accrued expenses 7,704     6,609
Deferred income taxes 3,063     2,996
Total Liabilities 96,447     57,436
Retained earnings 44,055     43,556
Total CVS Health shareholders’ equity 38,688     37,691
Total shareholders’ equity 38,692     $ 37,695
Total liabilities and shareholders’ equity 135,139      
Reconciliation of net income to net cash provided by operating activities:        
Net income 1,000      
Deferred income taxes and other noncash items 63      
Accrued expenses $ 1,228